BGM Group (BGM) Stock Overview
Through its subsidiaries, operates as a pharmaceutical and chemical company in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BGM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BGM Group Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.32 |
| 52 Week High | US$17.17 |
| 52 Week Low | US$8.21 |
| Beta | 0 |
| 1 Month Change | -22.93% |
| 3 Month Change | -6.78% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -13.64% |
Recent News & Updates
Shareholder Returns
| BGM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -20.1% | 0.1% | 2.9% |
| 1Y | n/a | -11.8% | 13.9% |
Return vs Industry: Insufficient data to determine how BGM performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BGM performed against the US Market.
Price Volatility
| BGM volatility | |
|---|---|
| BGM Average Weekly Movement | 15.5% |
| Pharmaceuticals Industry Average Movement | 11.5% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 4.0% |
Stable Share Price: BGM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine BGM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 323 | Chen Xin | www.bgmgroupltd.com |
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions.
BGM Group Ltd. Fundamentals Summary
| BGM fundamental statistics | |
|---|---|
| Market cap | US$1.95b |
| Earnings (TTM) | -US$1.44m |
| Revenue (TTM) | US$25.10m |
Is BGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGM income statement (TTM) | |
|---|---|
| Revenue | US$25.10m |
| Cost of Revenue | US$20.98m |
| Gross Profit | US$4.11m |
| Other Expenses | US$5.56m |
| Earnings | -US$1.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0078 |
| Gross Margin | 16.39% |
| Net Profit Margin | -5.75% |
| Debt/Equity Ratio | 0% |
How did BGM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/01 21:38 |
| End of Day Share Price | 2025/07/01 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BGM Group Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.